Live feed07:30:00·14dPRReleasevia QuantisnowOrganon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19ByQuantisnow·Wall Street's wire, on your screen.OGN· Organon & Co.Health Care
